BioCentury
ARTICLE | Company News

APT Therapeutics, AZ deal

January 20, 2017 7:32 PM UTC

The companies partnered to develop APT's APT102. APT will receive an upfront payment and is eligible for development milestones. AstraZeneca, which has an option to acquire the product, will fund tria...